Philadelphia – Day 3 of the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics meeting continues to deliver on high quality talks with excellent data to discuss and parse.

Dr Jay Bradner (NIBR) at #Targets17

The session on epigenetics and transcription factors is always one of my favourites and this year didn’t disappoint.

There were also sessions on imaging, non-mutated genes, the tumour microenvironment and of course, a long poster session to browse.  Thankfully the poster halls weren’t as mobbed as they were at ASCO earlier in the year, but they were still pretty busy and well attended.

To learn more insights from this cancer conference, subscribers can log-in or you can click to gain access to BSB Premium Content.

This content is restricted to subscribers

Posted by